INKT - Mink Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - INKT (1840229)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
8 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2023-10-12
INKTAgenus Inc10%P - Purchase$1.10+22,97521,772,8630%+$25,270
2023-10-04
INKTAgenus Inc10%P - Purchase$1.09+15,00121,749,8880%+$16,380
2023-08-29
INKTAgenus Inc10%P - Purchase$1.52+29,67821,734,8870%+$45,016
M
2023-08-24
INKTAgenus Inc10%P - Purchase$1.54+183,05221,705,209+1%+$281,478
M
2023-05-10
INKTAgenus Inc10%P - Purchase$1.47+45,42621,640,4730%+$66,644
2023-05-05
INKTArmen Garo HDirS - Sale$0.95-100,0001,866,400-5%-$94,850
M
2023-05-03
INKTAgenus Inc10%P - Purchase$1.04+250,36221,595,047+1%+$260,189
2023-05-02
INKTArmen Garo HDirP - Purchase$0.95+100,0001,978,010+5%+$94,850

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top